Results 91 to 100 of about 24,887 (213)

The inhibitory effect of octreotide on experimental colorectal carcinogenesis [PDF]

, 2002
Purpose. This study was conducted to investigate the effect of octreotide on colorectal carcinogenesis by administering octreotide either alone or combined with polyglactin, which is a well-known suture material, on chemically induced colorectal cancer ...

core   +1 more source

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis

BMC Pharmacology and Toxicology, 2017
Background Many patients with acromegaly require medical treatment that includes somatostatin analogs (SSAs). Long-acting SSA formulations are widely used, due in part to increased patient convenience and increased treatment adherence vs daily ...
Michelle H. Gurel, Yi Han, Andrea L. Stevens, Aaron Furtado, David Cox   +4 more
doaj   +1 more source

Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis [PDF]

, 2006
Idiopathic pulmonary fibrosis (IPF) is characterized by an uncontrolled accumulation and activation of lung fibroblasts. A modulation of fibroblast activation has been observed in various systems with octreotide, a synthetic somatostatin analog with ...
Marchand-Adam, Sylvain, Crestani, Bruno, Raguin, Olivier, Gruaz-Guyon, Anne, Marchal, Joëlle, Le Guludec, Dominique, Lebtahi, Rachida, Debray, Marie-Pierre, Brauner, Michel, Reubi, Jean-Claude, Moreau, Severine, Soler, Paul   +11 more
core  

Use of octreotide for the treatment of protein‐losing enteropathy in dogs: Retrospective study of 18 cases

Journal of Veterinary Internal Medicine
Background More than 50% of dogs with protein‐losing enteropathy (PLE) fail to respond to standard therapies. Octreotide, a somatostatin analogue, is used in cases of intestinal lymphangiectasia (IL) in humans with some success.
Sara A. Jablonski, Allison S. W. Mazepa, M. Katherine Tolbert   +2 more
doaj   +1 more source

Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging‐Guided Diagnosis and Therapy

Chemistry – A European Journal, Volume 32, Issue 30, 13 August 2026.
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan, Yupeng Liu, Jinyun Tan, Songnan Qu   +3 more
wiley   +1 more source

Review of nutrition management of pediatric intestinal pseudo‐obstruction

Nutrition in Clinical Practice, Volume 41, Issue 4, Page 1048-1060, August 2026.
Abstract Chronic intestinal pseudo‐obstruction (CIPO) is a rare, heterogeneous, and debilitating disorder characterized by profound intestinal dysmotility and severe nutrition challenges. Its presentation resembles that of mechanical bowel obstruction, but CIPO occurs in the absence of luminal obstruction.
Senthilkumar Sankararaman, Raisa Rani James, Bushra El‐Amaireh, Andrea Adler, Kadakkal Radhakrishnan, Sujithra Velayuthan   +5 more
wiley   +1 more source

Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases

Scientific Reports
Lanreotide and Octreotide are used to treat various endocrine and neoplastic diseases. This study aims to compare the adverse event profiles of Lanreotide and Octreotide in somatostatin-responsive diseases using FAERS data.
Le Wang, Shenglin Chen, Mengying Wu, Lijuan Zhou   +3 more
doaj   +1 more source

Chylothorax Following Endoscopic Ultrasound‐Guided Fine‐Needle Aspiration: A Rare Complication and Its Anatomical Risk Factors

Respirology Case Reports, Volume 14, Issue 8, August 2026.
This case describes the successful conservative management of chylothorax, a rare complication following EUS‐FNA. A low‐output leak of 260 mL/day resolved fully within days using intercostal chest drainage, dietary modification and octreotide therapy.
Saima Bandarkar, Ahmed Abdelsamad, Yousef Aleid, Ahmed Nasr, Talal AlSaeed, Essa AlGunaim, Derar AlShehab, Adel Ayed, Mohammed I. Ghanbar, Sulaiman Khadadah   +9 more
wiley   +1 more source

Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal [PDF]

, 1991
1. Exogenous somatostatin inhibits glucagon secretion and prevents ketoacidosis in diabetic patients, but has the therapeutic disadvantage of requiring continuous intravenous infusion to exhibit these effects. 2.
Diem, P, P Diem, RP Robertson, Robertson, RP   +3 more
core   +1 more source

Local arterial vasoconstriction induced by octreotide in patients with cirrhosis [PDF]

, 2019
Peripheral vasodilation initiates the hyperdynamic circulation in cirrhosis. Somatostatin and its analogues, such as octreotide, have a vasoconstrictive effect in cirrhotic patients and experimental animals with portal hypertension.
Gupta, Tarun, Chatila, Rajaa, Groszmann, Roberto, Ferayorni, Lisa   +3 more
core   +1 more source